はじめての方へ
ショーケース
価格
ログイン
無料体験
米国企業
iTeos Therapeutics, Inc.
iTeos Therapeutics, Inc.
ITOS
時価総額
$5億
PER
マイリストに追加
マイリストに追加
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
損益計算書
バランスシート
キャッシュフロー
2020年
12月31日
2021年
12月31日
2022年
12月31日
Cash and cash equivalents
336
849
285
Short-Term Investments
-
-
328
Grants receivable
0
4
1
Research and development tax credits receivable
0
1
-
Refundable income taxes
-
8
1
Prepaid expenses and other current assets
3
14
13
Total current assets
340
875
628
Property and equipment, net
1
2
2
Long-Term Investments
-
-
118
Research And Development Tax Credit Receivable Non Current
3
2
1
Restricted cash
0
0
0
Right of use assets
-
5
5
Other assets
0
0
0
Total assets
345
885
755
Accounts payable
3
5
8
Accrued expenses and other current liabilities
7
17
20
Deferred income
4
1
1
Deferred revenue
-
280
13
Lease liabilities
-
1
1
Total current liabilities
15
304
42
Grants repayable
6
6
7
Operating Lease, Liability, Noncurrent
-
5
4
Unrecognized tax benefits
-
17
39
Other noncurrent liabilities
0
0
-
Total liabilities
21
332
92
Common Stock, Value, Issued
0
0
0
Additional paid-in capital
396
413
436
Accumulated other comprehensive (loss)
1
-1
-10
Retained earnings
-74
141
237
Total stockholders' equity
323
553
663
Total liabilities and stockholders' equity
345
885
755